isabelobrien, Author at European Medical Journal - Page 51 of 66

In data we trust: how to nail consent and preference management

The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules

Amgen's Tamika Jean-Baptiste on creating an equitable experience

An interview with Tamika-Jean Baptiste, Vice President and Chief Diversity Officer, Amgen.

The value of purpose

The corporate environment is evolving, and ‘purpose’ is more important than ever to young recruits looking for their next role. We examine how the pharmaceutical industry is embracing the importance of purpose for retention, reputation, and brand differentiation

Sustainable solutions for a greener tomorrow

From drug development to disposal, how can all processes and functions be considered through a greener lens, and work towards a healthier and safer future?

The hard sell of cell and gene therapies

While the potential of cell and gene therapies (CGTs) is huge, the high cost raises concerns from payers. We explore how the industry can drive the adoption of CGTs to ensure that they reach patients around the world, rather than just those in private markets

Seeking solutions to low income low access

During the pandemic, low-to-middle-income countries (LMICs) have often been reliant on vaccine handouts from global initiatives and affluent nations. What are the emerging solutions that could improve access to vaccines in LMICs and self-sufficiency?

What is possible with preventative technology?

Tech giants have seized a huge share of the health and preventive technology market, but how could partnerships between the pharmaceutical and tech industries benefit patients and healthcare systems?

Clare Hague on drug pricing and market access

Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen, discusses drug pricing.

Julie Ross on International Equal Pay Day

Julie Ross, President, Advanced Clinical, talks about gender parity in the workplace in aid of International Equal Pay Day.

Carol Ross on corporate responsibility

Carol Lynch, Chief Business Officer, Sandoz, talks about how to increase the number of women in leadership positions in pharma and more.